Skip to main content
Wenbin Xiao, MD, Pathology, New York, NY

WenbinXiaoMD

Pathology New York, NY

Hematopathology, Anatomic Pathology, Clinical Pathology

Associate Attending

Dr. Xiao is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Xiao's full profile

Already have an account?

  • Office

    1275 York Avenue
    New York, NY 10065

Summary

  • Dr. Wenbin Xiao is a pathologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. He received his medical degree from Peking University and has been in practice 14 years. He specializes in hematopathology, anatomic pathology, and clinical pathology and is experienced in leukemia and lymphoma.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematopathology, 2014 - 2016
  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Pathology-Anatomic and Clinical, 2010 - 2014
  • Beijing Medical University
    Beijing Medical UniversityClass of 2003, MD

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2021 - 2025
  • NY State Medical License
    NY State Medical License 2016 - 2025
  • PA State Medical License
    PA State Medical License 2013 - 2016
  • OH State Medical License
    OH State Medical License 2010 - 2014
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • American Board of Pathology Pathology - Hematology

Publications & Presentations

PubMed

Abstracts/Posters

  • A Phase I Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory CLL / SLLA Phase I Study of Duvelisib and Venetoclax in Patients with Relapsed or R...
    Jennifer R Brown, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Acute Leukemia with Lineage Infidelity: Mixed Phenotype AML Exhibits a Distinct Immunophenotype with Clinical Features Overlapping Mixed Phenotype Acute Leukemia
    Wenbin Xiao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Stag2 Regulates Hematopoietic Differentiation and Self-Renewal through Alterations in Gene Expression and Topological Control
    Wenbin Xiao, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Loss of Plasmacytoid Dendritic Cell Differentiation Is Highly Predictive for Persistent Measurable Residual Disease and Poor Outcomes in Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Mission Bio Launches Single-Cell MRD Assay for Blood Cancer Patients
    Mission Bio Launches Single-Cell MRD Assay for Blood Cancer PatientsSeptember 28th, 2023